Deal Announcements & Amendments

4 articles this week

Globa Terra (GTERA) to Combine with Nature’s Ledger in $324M Deal

Globa Terra (NASDAQ:GTERA) has entered into a definitive agreement to combine with sustainability firm Nature’s Ledger at a $323.8 million pre-money equity value. Nature's Ledger places real world ecological assets on the blockchain to allow investors to trade carbon credits based on their preservation or improvement. More

Nicholas Alan Clayton·Nov 9

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More

Nicholas Alan Clayton·Nov 6

BHAV I (BHAV) to Combine with Nemi Corp. in $400M Deal

BHAV I (NASDAQ:BHAV) has entered into a definitive agreement to combine with automated manufacturing firm Nemi Corp. at a pre-money equity value of $400 million. India-based Nemi is developing software and hardware for autonomous manufacturing that it plans to provide as a service to enterprise clients. More

Nicholas Alan Clayton·Nov 5

GP-Act III (GPAT) to Combine with Dronamics Group in $497M Deal

GP-Act III (NASDAQ:GPAT) has entered into a definitive agreement to combine with cargo drone maker Dronamics at a pro forma enterprise value of $497 million. Dronamics is developing fixed-wing cargo drones for logistics services in both commercial and defense domains. More

Nicholas Alan Clayton·Nov 4

NorthStrive Acquisition Corp. I (NSAI) to Combine with Nuclea Energy in $350M Deal

NorthStrive I (NASDAQ:NSAI) has entered into a definitive agreement to combine with nuclear technology firm Nuclea Energy at an enterprise value of $350 million. Mississauga, Canada-based Nuclea is developing molten salt nuclear reactor designs that would be modular and scalable from 3. More

Nicholas Alan Clayton·Nov 2

Starlink AI (OTAI) to Combine with Spider Digital in $250M Deal

Starlink AI (NYSE:OTAI) has entered into a definitive agreement to combine with crypto mining firm Spider Digital at a $250 million valuation. Singapore-based Spider Digital provides pooled crypto mining resources and tools for miners and crypto financiers. More

Nicholas Alan Clayton·Nov 2

FG Imperii (FGII) to Combine with tZERO in $409M Deal

FG Imperii (NASDAQ:FGII) has entered into a definitive agreement to combine with digital asset firm tZERO at a pro forma enterprise value of $409 million. tZERO provides a platform for tokenizing real world assets and other financial products. More

Nicholas Alan Clayton·Nov 2

Amanat (AMAN) to Combine with Corxel US in $228M Deal

Amanat (NASDAQ:AMAN) has entered into a definitive agreement to combine with biotech firm Corxel Pharmaceuticals at an enterprise value of $228 million. Corxel is developing an oral GLP-1 weight-loss drug as well as other potential treatments. More

Nicholas Alan Clayton·Oct 26

APEX Tech (TRAD) to Combine with Korai Flix in $3.5Bn Deal

APEX Tech (NYSE:TRAD) has entered into a definitive agreement to combine with South Korean film studio Korai Flix at a $3.5 billion pre-money equity value. Korai Flix has launched an online content platform that provides AI-generated short films and allows users to produce their own interactive content with AI avatars. More

Nicholas Alan Clayton·Oct 21

TCGX (TCGX) to Combine with TriGemX Bio in $403M Deal

TCGX I (NASDAQ:TCGX) has signed a definitive agreement to combine with drug developer TriGemX Bio at a pro forma enterprise value of $402.8 million. New York-based TriGemX Bio is developing a drug candidate for the treatment of acute migraines that is currently in Phase III trials. More

Nicholas Alan Clayton·Oct 19